glp 1 neurotransmitter From metabolism to mind: The expanding role of the GLP-1 receptor in neurotherapeutics Glucagon‐like peptide‐1 (GLP‐1) signalling in

Likelihood of major adverse cardiovascular events Source: Bohula, et al New Engl J Med November 8, 2025 The New England Journal reported last month that evolocumab (Repatha), a PCSK9 drug that lowers cholesterol substantially decreased the rate of new major adverse cardiovascular events (MACE) in people who were at high risk but had never had a heart attack

You joined the gym

The result is a system where traditional pharma is hyper-regulated for transparency and risk disclosure, while digital-first startups can operate with influencer-style freedom

The premise behind the gelatin trick is that the unique amino acid profile of gelatin approximately 33% glycine, 11% alanine, plus proline and hydroxyproline triggers natural satiety hormones, slows gastric emptying, stabilises blood sugar response to the upcoming meal, and reduces total daily calorie intake without willpower battles or restrictive eating plans